PROGEN Biotechnik Overview
- Year Founded
-
1983
- Status
-
Acquired/Merged
- Employees
-
49
- Latest Deal Type
-
Series B
- Financing Rounds
-
3
- Investments
-
1
PROGEN Biotechnik General Information
Description
Manufacturer and supplier of premium antibodies intended to serve the global life science research community. The company specializes in the development of antibodies, in vitro diagnostics and research reagents, thereby enabling scientists to be provided with products and ultimately deliver improved antibodies and exclusive adeno-associated viruses (AAV) products.
Contact Information
Website
www.progen.com(Operating Subsidiary)
Corporate Office
- Maaßstraße 30
- 69123 Heidelberg
- Germany
Corporate Office
- Maaßstraße 30
- 69123 Heidelberg
- Germany
PROGEN Biotechnik Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PROGEN Biotechnik Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PROGEN Biotechnik Patents
PROGEN Biotechnik Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102006010958-A1 | Method for carrying out a reaction for the amplification of a nucleic acid | Inactive | 06-Mar-2006 | ||
| DE-202006020486-U1 | Device for the detection of biomolecules | Inactive | 06-Mar-2006 | ||
| DE-202006020469-U1 | Device for detecting biochemical target molecules | Inactive | 06-Mar-2006 | ||
| EP-1993730-A1 | Method of carrying out a reaction for replicating a nucleic acid | Inactive | 06-Mar-2006 | ||
| DE-102005008224-B3 | Apparatus for automatically activating microfluid device, for carrying out biochemical purifications and assays, having activator controlled on the basis of measurements of exerted force | Inactive | 23-Feb-2005 | B01L3/0293 |
PROGEN Biotechnik Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PROGEN Biotechnik Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PROGEN Biotechnik Acquisitions (1)
PROGEN Biotechnik’s most recent deal was a Merger/Acquisition with MICROBIONIX. The deal was made on 01-Jan-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MICROBIONIX | 01-Jan-2011 | Merger/Acquisition | Laboratory Services (Healthcare) |
PROGEN Biotechnik FAQs
-
When was PROGEN Biotechnik founded?
PROGEN Biotechnik was founded in 1983.
-
Where is PROGEN Biotechnik headquartered?
PROGEN Biotechnik is headquartered in Heidelberg, Germany.
-
What is the size of PROGEN Biotechnik?
PROGEN Biotechnik has 49 total employees.
-
What industry is PROGEN Biotechnik in?
PROGEN Biotechnik’s primary industry is Biotechnology.
-
Is PROGEN Biotechnik a private or public company?
PROGEN Biotechnik is a Private company.
-
What is the current valuation of PROGEN Biotechnik?
The current valuation of PROGEN Biotechnik is .
-
What is PROGEN Biotechnik’s current revenue?
The current revenue for PROGEN Biotechnik is .
-
How much funding has PROGEN Biotechnik raised over time?
PROGEN Biotechnik has raised $33M.
-
Who are PROGEN Biotechnik’s investors?
November (Diagnostic Equipment) has invested in PROGEN Biotechnik.
-
When was PROGEN Biotechnik acquired?
PROGEN Biotechnik was acquired on 05-Apr-2023.
-
Who acquired PROGEN Biotechnik?
PROGEN Biotechnik was acquired by R-Biopharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
